SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-218513
Filing Date
2019-08-12
Accepted
2019-08-12 08:01:12
Documents
11
Period of Report
2019-08-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d674165d8k.htm 8-K 50047
2 EX-3.1 d674165dex31.htm EX-3.1 51678
3 EX-10.1 d674165dex101.htm EX-10.1 265223
4 EX-10.2 d674165dex102.htm EX-10.2 77776
5 EX-10.3 d674165dex103.htm EX-10.3 7391
6 EX-99.1 d674165dex991.htm EX-99.1 35799
7 EX-99.2 d674165dex992.htm EX-99.2 158331
8 GRAPHIC g674165g34f83.jpg GRAPHIC 68141
9 GRAPHIC g674165g71v66.jpg GRAPHIC 62427
10 GRAPHIC g674165g74r21.jpg GRAPHIC 61904
11 GRAPHIC g674165g81p11.jpg GRAPHIC 67094
  Complete submission text file 0001193125-19-218513.txt   1006091
Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223
AQUINOX PHARMACEUTICALS, INC (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36327 | Film No.: 191014404
SIC: 2834 Pharmaceutical Preparations